missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MMAF Monoclonal Antibody (A5G12)

Descripción
Product has been tested in direct ELISA.
Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. Monomethyl auristatin F is an antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. It is linked to an antibody with high affinity to structures on cancer cells, causing MMAF to accumulate in such cells. MMAF is actually desmethyl-auristatin F; that is, the N-terminal amino group has only one methyl substituent instead of two as in auristatin F itself.
Especificaciones
Especificaciones
| Antígeno | MMAF |
| Aplicaciones | ELISA |
| Clasificación | Monoclonal |
| Clon | A5G12 |
| Concentración | 2 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 40% glycerol, 0.1% BSA and 0.05% sodium azide; pH 7.4 |
| Alias de gen | Monomethyl auristatin F |
| Especie del huésped | Mouse |
| Inmunógeno | MMAF coupled with OVA. |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?